110 related articles for article (PubMed ID: 3438782)
1. Efficacy of interferon and placebo in the treatment of recurrent genital herpes: a double-blind trial.
Lassus A; Bergelin I; Paloranta A; Rinne E; Eskelinen A; Säilä K
Sex Transm Dis; 1987; 14(4):185-90. PubMed ID: 3438782
[TBL] [Abstract][Full Text] [Related]
2. Human leukocyte interferon-alpha in cream for the treatment of genital herpes in Asian males. A placebo-controlled, double-blind study.
Syed TA; Cheema KM; Kahlon BM; Kahlon RC; Khayyami M; Kahlon AM; Kahlon MM
Dermatology; 1995; 191(1):32-5. PubMed ID: 8589479
[TBL] [Abstract][Full Text] [Related]
3. Leukocyte interferon for treating first episodes of genital herpes in women.
Pazin GJ; Harger JH; Armstrong JA; Breinig MK; Caplan RJ; Cantell K; Ho M
J Infect Dis; 1987 Dec; 156(6):891-8. PubMed ID: 2824623
[TBL] [Abstract][Full Text] [Related]
4. Therapy of genital herpes with topically applied interferon.
Eron LJ; Toy C; Salsitz B; Scheer RR; Wood DL; Nadler PI
Antimicrob Agents Chemother; 1987 Jul; 31(7):1137-9. PubMed ID: 3310870
[TBL] [Abstract][Full Text] [Related]
5. Randomized, double-blind, placebo-controlled, patient-initiated study of topical high- and low-dose interferon-alpha with nonoxynol-9 in the treatment of recurrent genital herpes.
Sacks SL; Varner TL; Davies KS; Rekart ML; Stiver HG; DeLong ER; Sellers PW
J Infect Dis; 1990 Apr; 161(4):692-8. PubMed ID: 2156945
[TBL] [Abstract][Full Text] [Related]
6. Intravenous acyclovir therapy of first episodes of genital herpes: a multicenter double-blind, placebo-controlled trial.
Peacock JE; Kaplowitz LG; Sparling PF; Durack DT; Gnann JW; Whitley RJ; Lovett M; Bryson YJ; Klein RJ; Friedman-Kien AE
Am J Med; 1988 Sep; 85(3):301-6. PubMed ID: 3046350
[TBL] [Abstract][Full Text] [Related]
7. Interferon in the prevention of genital herpes recurrence.
Eron LJ; Harvey L; Toy C; Santomauro D
Antimicrob Agents Chemother; 1986 Oct; 30(4):608-10. PubMed ID: 3789694
[TBL] [Abstract][Full Text] [Related]
8. Placebo-controlled trial of topical interferon in labial and genital herpes.
Glezerman M; Lunenfeld E; Cohen V; Sarov I; Movshovitz M; Doerner T; Shoham J; Revel M
Lancet; 1988 Jan; 1(8578):150-2. PubMed ID: 2892991
[TBL] [Abstract][Full Text] [Related]
9. Recombinant alpha-2 interferon gel treatment of recurrent herpes genitalis.
Lebwohl M; Sacks S; Conant M; Connor J; Douglas JM; Eron L; Marlowe S; Mendelson J; Chen V; Bradstreet P
Antiviral Res; 1992 Mar; 17(3):235-43. PubMed ID: 1567188
[TBL] [Abstract][Full Text] [Related]
10. Human leukocyte interferon-alpha in a hydrophilic cream versus in a gel for the treatment of genital herpes in males: a placebo-controlled, double-blind, comparative study.
Syed TA; Ahmadpour OA; Ahmad SA; Ahmad SH
J Dermatol; 1997 Sep; 24(9):564-8. PubMed ID: 9350101
[TBL] [Abstract][Full Text] [Related]
11. Suppression of recurrent genital herpes simplex virus infection with recombinant alpha 2 interferon.
Kuhls TL; Sacher J; Pineda E; Santomauro D; Wiesmeier E; Growdon WA; Bryson YJ
J Infect Dis; 1986 Sep; 154(3):437-42. PubMed ID: 3525695
[TBL] [Abstract][Full Text] [Related]
12. Recurrent condylomata acuminata treated with recombinant interferon alfa-2a. A multicenter double-blind placebo-controlled clinical trial. Condylomata International Collaborative Study Group.
JAMA; 1991 May 22-29; 265(20):2684-7. PubMed ID: 2023348
[TBL] [Abstract][Full Text] [Related]
13. Natural interferon alfa for treatment of condylomata acuminata.
Friedman-Kien AE; Eron LJ; Conant M; Growdon W; Badiak H; Bradstreet PW; Fedorczyk D; Trout JR; Plasse TF
JAMA; 1988 Jan 22-29; 259(4):533-8. PubMed ID: 3336177
[TBL] [Abstract][Full Text] [Related]
14. Comparison of intramuscular recombinant alpha interferon (rIFN-2A) with topical acyclovir for the treatment of first-episode herpes genitalis and prevention of recurrences.
Levin MJ; Judson FN; Eron L; Bryson YJ; Corey L; Murray M; Scheer RR
Antimicrob Agents Chemother; 1989 May; 33(5):649-52. PubMed ID: 2751279
[TBL] [Abstract][Full Text] [Related]
15. Recombinant interferon alpha-2a for treatment of herpes zoster in immunosuppressed patients with cancer.
Winston DJ; Eron LJ; Ho M; Pazin G; Kessler H; Pottage JC; Gallagher J; Sartiano G; Ho WG; Champlin RE
Am J Med; 1988 Aug; 85(2):147-51. PubMed ID: 3041829
[TBL] [Abstract][Full Text] [Related]
16. Double-blind, placebo-controlled trial comparing long-term suppressive with short-term oral acyclovir therapy for management of recurrent genital herpes.
Mattison HR; Reichman RC; Benedetti J; Bolgiano D; Davis LG; Bailey-Farchione A; Remington M; Winter C; Corey L
Am J Med; 1988 Aug; 85(2A):20-5. PubMed ID: 3044086
[TBL] [Abstract][Full Text] [Related]
17. Interferon alfa-2a in the treatment of Behçet disease: a randomized placebo-controlled and double-blind study.
Alpsoy E; Durusoy C; Yilmaz E; Ozgurel Y; Ermis O; Yazar S; Basaran E
Arch Dermatol; 2002 Apr; 138(4):467-71. PubMed ID: 11939808
[TBL] [Abstract][Full Text] [Related]
18. Single-day, patient-initiated famciclovir therapy for recurrent genital herpes: a randomized, double-blind, placebo-controlled trial.
Aoki FY; Tyring S; Diaz-Mitoma F; Gross G; Gao J; Hamed K
Clin Infect Dis; 2006 Jan; 42(1):8-13. PubMed ID: 16323085
[TBL] [Abstract][Full Text] [Related]
19. Effect of recombinant interferon alpha 2 on clinical course of first episode genital herpes infection and subsequent recurrences.
Mendelson J; Clecner B; Eiley S
Genitourin Med; 1986 Apr; 62(2):97-101. PubMed ID: 3087862
[TBL] [Abstract][Full Text] [Related]
20. Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial.
Manns M; Marcellin P; Poordad F; de Araujo ES; Buti M; Horsmans Y; Janczewska E; Villamil F; Scott J; Peeters M; Lenz O; Ouwerkerk-Mahadevan S; De La Rosa G; Kalmeijer R; Sinha R; Beumont-Mauviel M
Lancet; 2014 Aug; 384(9941):414-26. PubMed ID: 24907224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
